SEC Form 10-Q filed by Omega Alpha SPAC

15-12G - Omega Alpha SPAC (0001832010) (Filer)

25-NSE - Omega Alpha SPAC (0001832010) (Subject)

8-K - Omega Alpha SPAC (0001832010) (Filer)

BOSTON, Dec. 17, 2021 /PRNewswire/ -- Omega Funds, a leading international healthcare venture capital firm focused on delivering impactful medicines to patients, today announced it has closed its seventh and largest fund with $650 million in limited partner capital commitments. The new fund, Omega Fund VII, L.P. ("Fund VII"), was oversubscribed, exceeding the firm's targeted raise of $500 million, and included strong support from both new and existing limited partners. With Fund VII, the firm will continue to execute on its strategy of creating and investing in life sciences companies in the US and Europe that target severe, unmet medical needs. Since its inception in 2004, Omega Funds has r

SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)

SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)

SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)